AIMS/HYPOTHESIS: Little is known about the subcellular distribution of lipids in insulin-resistant skeletal muscle. However, it has recently been suggested that lipid accumulation in the subsarcolemmal region directly contributes to insulin resistance. Therefore we hypothesised that regional differences in lipid distribution in insulin-resistant muscle may be mediated by: (1) a reduction in fatty acid trafficking into mitochondria; and/or (2) a regional increase in the enzymes regulating lipid synthesis. METHODS: Transmission electron microscopy was used to quantify lipid droplet and mitochondrial abundance in the subsarcolemmal and intermyofibrillar compartments in red and white muscles from lean and obese Zucker rats. To estimate rates of lipid trafficking into mitochondria, the metabolic fate of radiolabelled palmitate was determined. Key enzymes of triacylglycerol synthesis were also determined in each subcellular region. RESULTS: Subsarcolemmal-compartmentalised lipids represented a small absolute fraction of the overall lipid content in muscle, as regardless of fibre composition (red/white) or phenotype (lean/obese), lipid droplets were more prevalent in the intermyofibrillar region, whereas insulin-resistant white muscles were devoid of subsarcolemmal-compartmentalised lipid droplets. While, in obese animals, lipid droplets accumulated in both subcellular regions, in red muscle of these animals lipids only appeared to be trafficked away from intermyofibrillar mitochondria, a process that cannot be explained by regional differences in the abundance of triacylglycerol esterification enzymes. CONCLUSIONS/ INTERPRETATION: Lipid accumulation in the subsarcolemmal region is not necessary for insulin resistance. In the intermyofibrillar compartment, the diversion of lipids away from mitochondria in insulin-resistant animals probably contributes to lipid accumulation in this subcellular area.
AIMS/HYPOTHESIS: Little is known about the subcellular distribution of lipids in insulin-resistant skeletal muscle. However, it has recently been suggested that lipid accumulation in the subsarcolemmal region directly contributes to insulin resistance. Therefore we hypothesised that regional differences in lipid distribution in insulin-resistant muscle may be mediated by: (1) a reduction in fatty acid trafficking into mitochondria; and/or (2) a regional increase in the enzymes regulating lipid synthesis. METHODS: Transmission electron microscopy was used to quantify lipid droplet and mitochondrial abundance in the subsarcolemmal and intermyofibrillar compartments in red and white muscles from lean and obese Zucker rats. To estimate rates of lipid trafficking into mitochondria, the metabolic fate of radiolabelled palmitate was determined. Key enzymes of triacylglycerol synthesis were also determined in each subcellular region. RESULTS: Subsarcolemmal-compartmentalised lipids represented a small absolute fraction of the overall lipid content in muscle, as regardless of fibre composition (red/white) or phenotype (lean/obese), lipid droplets were more prevalent in the intermyofibrillar region, whereas insulin-resistant white muscles were devoid of subsarcolemmal-compartmentalised lipid droplets. While, in obese animals, lipid droplets accumulated in both subcellular regions, in red muscle of these animals lipids only appeared to be trafficked away from intermyofibrillar mitochondria, a process that cannot be explained by regional differences in the abundance of triacylglycerol esterification enzymes. CONCLUSIONS/ INTERPRETATION:Lipid accumulation in the subsarcolemmal region is not necessary for insulin resistance. In the intermyofibrillar compartment, the diversion of lipids away from mitochondria in insulin-resistant animals probably contributes to lipid accumulation in this subcellular area.
Authors: Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio Journal: Cell Metab Date: 2008-01 Impact factor: 27.287
Authors: Carley R Benton; James G Nickerson; James Lally; Xiao-Xia Han; Graham P Holloway; Jan F C Glatz; Joost J F P Luiken; Terry E Graham; John J Heikkila; Arend Bonen Journal: J Biol Chem Date: 2007-12-12 Impact factor: 5.157
Authors: D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien Journal: Diabetes Date: 1997-06 Impact factor: 9.461
Authors: D J Dyck; S J Peters; J Glatz; J Gorski; H Keizer; B Kiens; S Liu; E A Richter; L L Spriet; G J van der Vusse; A Bonen Journal: Am J Physiol Date: 1997-03
Authors: Justin D Crane; Michaela C Devries; Adeel Safdar; Mazen J Hamadeh; Mark A Tarnopolsky Journal: J Gerontol A Biol Sci Med Sci Date: 2009-12-03 Impact factor: 6.053
Authors: Hakam Alkhateeb; Adrian Chabowski; Jan F C Glatz; Joost F P Luiken; Arend Bonen Journal: Am J Physiol Endocrinol Metab Date: 2007-06-05 Impact factor: 4.310
Authors: Brennan K Smith; Kazutaka Mukai; James S Lally; Amy C Maher; Brendon J Gurd; George J F Heigenhauser; Lawrence L Spriet; Graham P Holloway Journal: J Physiol Date: 2013-01-07 Impact factor: 5.182
Authors: Arend Bonen; Swati S Jain; Laelie A Snook; Xiao-Xia Han; Yuko Yoshida; Kathryn H Buddo; James S Lally; Elizabeth D Pask; Sabina Paglialunga; Marie-Soleil Beaudoin; Jan F C Glatz; Joost J F P Luiken; Ewa Harasim; David C Wright; Adrian Chabowski; Graham P Holloway Journal: Diabetologia Date: 2015-07-22 Impact factor: 10.122
Authors: Brennan K Smith; Christopher G R Perry; Timothy R Koves; David C Wright; Jeffrey C Smith; P Darrell Neufer; Deborah M Muoio; Graham P Holloway Journal: Biochem J Date: 2012-11-15 Impact factor: 3.857
Authors: Anne Gemmink; Madeleen Bosma; Helma J H Kuijpers; Joris Hoeks; Gert Schaart; Marc A M J van Zandvoort; Patrick Schrauwen; Matthijs K C Hesselink Journal: Diabetologia Date: 2016-02-10 Impact factor: 10.122
Authors: Luz M Acevedo; Ana I Raya; Julio M Martínez-Moreno; Escolástico Aguilera-Tejero; José-Luis L Rivero Journal: PLoS One Date: 2017-03-02 Impact factor: 3.240